Cargando…

382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins

Detalles Bibliográficos
Autores principales:	Recchiuti, A., Patruno, S., Mattoscio, D., Isopi, E., Pomilio, A., Pecce, R., Romano, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Cystic Fibrosis Society. 2021
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518458/ http://dx.doi.org/10.1016/S1569-1993(21)01806-3

Ejemplares similares

Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages
por: Recchiuti, Antonio, et al.
Publicado: (2021)

Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis
por: Isopi, Elisa, et al.
Publicado: (2020)

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
por: Recchiuti, Antonio, et al.
Publicado: (2019)

Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes
por: Mattoscio, Domenico, et al.
Publicado: (2021)

Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer
por: Mattoscio, Domenico, et al.
Publicado: (2022)

Diseño que seduce /
por: Anderson, Stephen P.
Publicado: (2012)

Seducers in Ecuador and Gottfried Künstler
por: Sackville-West, Vita 1892-1962
Publicado: (1944)

Proto-2 seduces America
Publicado: (2002)

Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review
por: Romano, Mario, et al.
Publicado: (2019)

Andy Martin: Seduced by CERN, but not convinced
Publicado: (2008)

microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A(4) receptor-dependent mechanisms of inflammation resolution and antimicrobial defense
por: Pierdomenico, Anna Maria, et al.
Publicado: (2017)

Resolvins and inflammatory pain
por: Sommer, Claudia, et al.
Publicado: (2011)

The masked seducers: Lek courtship behavior in the wrinkle-faced bat Centurio senex (Phyllostomidae)
por: Rodríguez-Herrera, Bernal, et al.
Publicado: (2020)

383: Cystic fibrosis macrophage function after elexacaftor/tezacaftor/ivacaftor initiation
por: Zhang, S., et al.
Publicado: (2021)

24. Chronic inflammatory arthritis in the context of cystic fibrosis
por: Clarke, Elizabeth, et al.
Publicado: (2019)

Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study
por: Hachulla, Eric, et al.
Publicado: (2016)

Resolvin D5 Inhibits Neuropathic and Inflammatory Pain in Male But Not Female Mice: Distinct Actions of D-Series Resolvins in Chemotherapy-Induced Peripheral Neuropathy
por: Luo, Xin, et al.
Publicado: (2019)

Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases
por: Ferri, Giulia, et al.
Publicado: (2023)

Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
por: Eickmeier, Olaf, et al.
Publicado: (2017)

Roles of Resolvins in Chronic Inflammatory Response
por: Liu, Chang, et al.
Publicado: (2022)

Role of Resolvins in Inflammatory and Neuropathic Pain
por: Park, Jaeik, et al.
Publicado: (2023)

235: COVID-19 vaccination in individuals with cystic fibrosis at a pediatric cystic fibrosis center
por: Elson, E., et al.
Publicado: (2021)

44: Characterizing the COVID-19 pandemic among Canadians living with cystic fibrosis: A Canadian Cystic Fibrosis Registry study
por: Cheng, S., et al.
Publicado: (2021)

Identification of distinct polarized macrophage subsets in inflammatory arthritis
por: Ambarus, C, et al.
Publicado: (2010)

51 Outcomes after SARS-CoV-2 infection in Canadians with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
por: Cheng, S., et al.
Publicado: (2022)

P220 Experiences of virtual cystic fibrosis clinics during the COVID-19 pandemic at one UK adult cystic fibrosis centre
por: Warnock, L., et al.
Publicado: (2021)

188: Cystic fibrosis kidney stone disease in the era of CFTR modulator use and the COVID-19 pandemic
por: Romano, S., et al.
Publicado: (2021)

Editorial: Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders
por: Sousa, Teresa, et al.
Publicado: (2023)

Role of Resolvins in the Inflammatory Resolution of Neurological Diseases
por: Li, Chunrong, et al.
Publicado: (2020)

418: Linezolid-resistant Staphylococcus aureus in patients with cystic fibrosis
por: Pitcher, N., et al.
Publicado: (2021)

666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice treated with human cystic fibrosis transmembrane conductance regulator messenger ribonucleic acid lipid nanoparticle
por: Mukherjee, A., et al.
Publicado: (2022)

P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)

P232 The impact of COVID-19 on the relationships between parents of young people diagnosed with cystic fibrosis and the cystic fibrosis multidisciplinary team
por: Jones, S., et al.
Publicado: (2021)

P146 COVID-19 pandemic in the Belgian cystic fibrosis patients compared with the international cystic fibrosis patients and the general Belgian population
por: Daneau, G., et al.
Publicado: (2023)

Resolvins on the way to resolution
por: Ward, Peter A.
Publicado: (2015)

miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1
por: Fang, Yi, et al.
Publicado: (2017)

Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways
por: Levy, Bruce D.
Publicado: (2012)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g5hil7tpvm28fsve7bk07f37q6